Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Alzheimer Disease (Phase 1)
Brain Diseases (Phase 1)
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 2)
Central Nervous System Neoplasms (Phase 1/Phase 2)
Corticobasal Degeneration (Phase 1)
Glioblastoma (Phase 2)
Hodgkin Disease (Phase 1)
Lymphoma, Non-Hodgkin (Phase 1)
Medulloblastoma (Phase 1/Phase 2)
Melanoma (Phase 1/Phase 2)
Movement Disorders (Phase 1)
Neoplasms (Phase 1)
Neuroblastoma (Phase 1/Phase 2)
Pancreatic Neoplasms (Phase 2)
Prostatic Neoplasms (Phase 2)
Recurrence (Phase 1)
Supranuclear Palsy, Progressive (Phase 1)
Tauopathies (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue